mail
versión imprimible
 
 

1st Rare and Genetic Neurodegenerative Drug Development Summit

Evvnt Promotion / evvnt
-
22.06.2022 - 23.06.2022  Online
Time: 08:50 - 16:00
 
Temas de la conferencia
Advance Life-Changing Therapies for Adolescents and Adults With Rare Neurological Disorders

Welcome to the 1st Rare and Genetic Neurodegenerative Drug Development Summit! This trailblazing meeting will be discussing, debating and exploring pivotal rare and genetic neurodegenerative disease research making industry news headlines.

Pioneers in this exclusive industry are convening online, this June, to network and learn from experts in pharma, biotech and academia.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Anka G. Ehrhardt, Director, Cell-Based Assays / Analytical Research and Development, Merck, Christopher Missling, President and Chief, Executive Officer, Anavex Life Sciences, David Theron, Development Director in Neurology, Servier & more
 

Información e inscripción:

https://go.evvnt.com/1056250-2?pid=4832
Mr. Hanson Wade
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Drug Developer Pricing - Conference Pass: USD 2099.0, Solution Provider Pricing - Conference Pass: USD 2599.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Helix - Forschung & Beratung WiennewTreeCenter of ExcellenceSwiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichische Gesellschaft für Public HealthÖsterreichisches Rotes Kreuz